Halozyme Therapeutics Inc
(NASDAQ:HALO)$38.44
-0.06[-0.16%]
Last update: 3:47PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$38.50
0.0600[0.16%]
After-Hours
| Open38.540 | Close- |
| Vol / Avg.622.911K / 889.067K | Mkt Cap5.078B |
| Day Range38.320 - 39.665 | 52 Wk Range29.850 - 59.450 |
Halozyme Therapeutics Stock (NASDAQ:HALO), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/06/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.70 | $2.80 | $2.65 | $825.00M | $845.00M | $835.91M | Get Alert |
| 08/08/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.65 | $2.75 | $2.61 | $825.00M | $845.00M | $823.06M | Get Alert |
| 05/09/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.50 | $2.65 | $2.57 | $815.00M | $845.00M | $833.00M | Get Alert |
| 03/15/2023 | HALO | Halozyme Therapeutics | FY | 2023 | — | — | — | $815.00M | $845.00M | $829.01M | Get Alert |
| 02/21/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.50 | $2.65 | $2.78 | $815.00M | $845.00M | $868.12M | Get Alert |
| 01/10/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.50 | $2.65 | $2.90 | $815.00M | $845.00M | $892.47M | Get Alert |
| 11/08/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.10 | $2.25 | $2.04 | $655.00M | $685.00M | $661.33M | Get Alert |
| 08/09/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.10 | $2.25 | $2.23 | $655.00M | $685.00M | $610.87M | Get Alert |
| 05/10/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.23 | $530.00M | $560.00M | $566.18M | Get Alert |
| 04/13/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.18 | $530.00M | $560.00M | $553.27M | Get Alert |
| 02/22/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.18 | $530.00M | $560.00M | $554.20M | Get Alert |
| 01/10/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.68 | $530.00M | $560.00M | $569.39M | Get Alert |
| 11/02/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.90 | $2.00 | — | $430.00M | $445.00M | — | Get Alert |
| 08/09/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.85 | $2.00 | $1.41 | $425.00M | $445.00M | $404.56M | Get Alert |
| 05/10/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.55 | $1.70 | $1.55 | $375.00M | $395.00M | $389.96M | Get Alert |
| 02/23/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.40 | $1.55 | $1.70 | $375.00M | $395.00M | $400.15M | Get Alert |
| 01/13/2021 | HALO | Halozyme Therapeutics | FY | 2020 | $0.90 | $0.95 | $0.93 | $265.00M | $275.00M | $265.30M | Get Alert |
| 01/11/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.40 | $1.55 | $1.79 | $375.00M | $395.00M | $403.71M | Get Alert |
| 11/23/2020 | HALO | Halozyme Therapeutics | FY | 2020 | $0.90 | $0.95 | $0.86 | $265.00M | $275.00M | $255.12M | Get Alert |
What is the most recent guidance for Halozyme Therapeutics (HALO)?
The last reported Earnings numbers were from November 6, 2023 for the full year 2023 and was for an earnings per share guidance in the range of $2.70 and $2.80 versus the estimated EPS of $2.65.
Browse guidance and forecast on all stocks.